Antibodies against eNS antigens in autism: Possible cross-reaction with dietary proteins and infectious agent antigens

Neuropsychiatric Disorders and Infection

Volumn , Issue , 2005, Pages 171-186

  Vojdani, Aristo ^a,b   Cooper, Edwin L ^b  

^a Immunosciences Laboratories Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953419318     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (69)

1. Noronha A, Arnason B. Demyelinating diseases. In: Clinical Immunology (Rich R, Fleisher TA, Schwartz B et al, eds). St Louis, MO: Mosby, 1995: 1364-76.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85:299-302.
3. Amor S, Baker D, Layward L et al. Multiple sclerosis: variations on a theme. Immunol Today 1997; 18: 368-71.
4. Raine CS, Cannella SL, Hauser CR Genain demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999; 46: 144-60.
5. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BJ. Multiple sclerosis, a review. N Engl J Med 2000; 343: 938-52.
6. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 1999; 5: 170-5.
7. Holz A, Bielekova B, Martin R, Oldstone MBA. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J Immunol 2000; 164: 1103-9.
8. Bajramovic JJ, Plomp AC, Van Der Goes A et al. Presentation of a-p-crystallin to T-cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. J Immunol 2000;164:4359-66.
9. Chou YK, Bourdette DN, Offner H et al. Frequency of T-cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. Neuroimmunol 1992; 38: 105.
10. Brock HPM, Uccelli A, Kerlero de Rosbo N et al. Myelin/oligo-dendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T-cell epitope P-MOG 24-36 is present by a monomorphic MHC class II molecule. ] Immunol 2000; 165: 1093-101.
11. Von Büdingen H, Tanuman N, Villaslada P et al. Immune response against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 2001;21:155-60.
12. Rodier PM, Ingram JL, Tisdale B et al. Embryological origin for autism: development abnormalities of the cranial nerve motor nuclei. Comp Neurol 1996; 370: 247-61.
13. Purcell AE, Rocco MM, Lenhart JA et al. Assessment of neuronal cell adhesion molecule (NCAM) in autistic serum and postmortem brain. J Autism Dev Discord 2001; 31: 183-93.
14. Weizman A, Weizman R, Szekely GA et al. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am JPsychiatry 1982; 139: 1462-5.
15. Singh VK, Warren RP, Odell JD et al. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993; 7: 97-103.
16. Singh VK, Warren RP, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament protein in autism. Pediatr Neurol 1997; 17: 88-90.
17. Vojdani A, Campbell AW, Anyanwu E et al. Antibodies to neuron-specific antigens in children with autism: possible crossreaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and streptococcus group A. J Neuroimmunol 2002; 129: 168-77.
18. Baba H, Daune GC, Ilyas A et al. Anti-GMj ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. Neuroimmunol 1989; 25: 143-50.
19. X and other ganglio-sides on PVDF-P membrane. Immunol Methods 1993; 165: 225-30.
20. Isoardo G, Ferrero B, Barbero P et al. Anti-GMj and anti-sul-fatide antibodies in polyneuropathies. Acta Neurol Scand 2001; 103:180-7.
21. Kaldor J, Speed BR. Guillain-Barre syndrome and Campylobacter jejuni: a serological study. BMJ 1984; 288: 1867-70.
22. Greunewald R, Ropper AH, Lior H. Serologic evidence of Campylobacter jejuni coli enteritis in patients with Guillain-Barre syndrome. Arch Neurol 1991; 48: 1080-2.
23. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998; 338: 1601-7.
24. Nemni R, Fazio R, Quattrini A et al. Antibodies to sulfatide and chondroitin sulfate in patients with chronic sensory neuropathy. Neuroimmunol 1993; 43: 79-86.
25. Fredman P, Lycke J, Anderson O et al. Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucoronyl-3-sulfate epitope. J Neurol 1993; 240: 381-7.
26. El-Fawal HAN, Gong Z, Little AR, Evans HL. Exposure to mercury results in serum autoantibodies to neurotype and glio-typic proteins. Neurotoxicology 1996; 17: 267-76.
27. El-Fawal HAN, Waterman SJ, DeFeo A, Shamy MY. Neuroimmunology: humoral assessment of neurotoxicity and autoimmune mechanism. Environ Health Perspect 1999; 5: 767-75.
28. Morse DC, Plug A, Wesseling W et al. Persistent alterations in regional brain glial fibrillary acidic protein and synpatophsin levels following pre- and postnatal polychlorinated biphenyl exposure. Toxic Appl Pharmacol 1996; 139: 252-61.
29. Parti S, Herbst H, Schaeper F et al. GFAP gene expression is altered in young rats following developmental low level lead exposure. Neurotoxicity 1998; 19: 547-52.
30. Qian Y, Harris ED, Zheng Y, Tiffany-Castiglioni E. Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells. Toxicol Pharmacol 2000; 163: 260-6.
31. Edelson SB, Cantor DS. Autism: xenobiotic influences. Toxicol Ind Health 1998; 14: 799-811.
32. Edelson SB, Cantor DS. The neurotoxic etiology of the autistic spectrum disorder: a replicative study. Toxicol Ind Health 2000; 16:239-47.
33. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985; 1: 1313-5.
34. Johnson RT, Griffin DE. Virus-induced autoimmune demyelinating disease of the central nervous system. In: Concepts in Viral Pathogenesis II (Notkins AL, Oldstone MBA, eds). New York: Springer, 1986: 203-9.
35. Rosener M, Harms F, Dichgans J, Martin R. Chickenpox and multiple sclerosis: a case report. J Neurol Neurosurgery Psychiatry 1995; 58: 637-8.
36. Zimmer C. Do chronic diseases have an infectious root? Science 2001; 293: 1974-7.
37. Wucherpfenning KW. Infectious trigger for inflammatory neurological disease. Nature Med 2002; 8: 455-7.
38. Fujunami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 203: 1043-5.
39. Wucherpfenning KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
40. Rajeswari MH, Ravindranath H, Graves MC. Monoclonal IgM antibodies from CMV-infected mice recognize the GICNAC-containing receptor determinant of murine CMV as well as neutralizing anti-CMV IgG antibodies. Virology 1992; 188: 143-51.
41. Moktarian F, Zhang Z, Shi Y et al. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein induces autoimmune demyelinating disease in mice. J Neuro-immunol 1999; 95: 43-8.
42. Esposito M, Venkatesh V, Otvos L et al. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. Immunol 1999; 163: 4027-32.
43. Caselli E, Boni M, Bracci A et al. Detection of antibodies directed against human herpesvirus-6 U 94/REP in sera of patients affected by multiple sclerosis. J Clin Microbiol 2002; 40:4131-7.
44. Olson JK, Eagar TN, Miller SD. Functional activation of myelin-specific T-cells by virus-induced mimicry. Immunol 2002; 169: 2719-26.
45. Bronze MS, Dale JB. Epitope of streptococcal M proteins that evoke antibodies that cross-react with the human brain. Immunol 1993; 151: 2820-8.
46. Lenz DC, Lu L, Conant SB et al. A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J Immunol 2001; 167: 1803-8.
47. Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive development disorder in children. Lancet 1998; 351: 637-41.
48. Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. J Pediatr 1978; 93: 669-703.
49. Ivarsson SA, Bjerre L, Vegfors P, Ahlfors K. Autism as one of several abnormalities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990; 21: 102-3.
50. Grogan JL, Kramer A, Nogai A et al. Cross-reactivity of myelin basic protein-specific T-cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. Immunol 1999; 163: 3764-70.
51. Fatemi SH, Earle J, Kanodia R et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002; 22: 25-33.
52. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavorial and pharmacological changes in the offspring. J Neurosciences 2003; 23: 297.
53. Stefferl A, Schubart A, Storch M et al. Butyrophilin, a milk protein, modulates the encephalitogenic T-cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Immunol 2000; 165: 2859-65.
54. Hadjivassiliou M, Grünewald RA, Lawden M et al. Headache and CNS white matter abnormalities related with gluten sensitivity. Neurology 2001; 56: 385-8.
55. Bürk L, Bösch, S, Müller CA. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001; 124: 1013-9.
56. Bushara KO, Goebel SU, Shill H et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001; 49: 540-3.
57. Sblattero D, Berti I, Trevisiol C. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for coeliac disease. Am J Gastroenterol 2000; 95: 1253-7.
58. Hadjivassiliou M, Boscolos S, Davies-Jones GAB et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58: 1221-6.
59. Dropcho EJ, Chen Y, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad 1987; 84: 4552-6.
60. Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerance in Celiac Sprue. Science 2002; 297: 2275-9.
61. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nature Rev Immunol 2002; 2: 647-55.
62. Vojdani A, Pangborn JB, Vojdani E, Cooper EL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are responsible for autoimmunity in autism. Int J Immunopath Pharmacol 2003; 16: 189-99.
63. Gonzalez-Gronow M, Weber MR, Gawdi G, Pizzo SV. Dipepti-dylpeptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts. Fibrinol Proteol 1998; 12: 129-35.
64. Chuchacovich M, Gatica H, Pizzo HSV, Gonzalez-Gronow M. Characterization of human serum dipeptidylpeptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. Clin Exp Rheumatol 2001; 19: 673-80.
65. Fabry Z, Raine CS, Hart MN. Nervous tissues as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994; 15: 218-24.
66. Wang J, Charboneau R, Barke RA et al. fx-opoid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J Immunol 2002; 169: 3630-6.
67. Rogers TJ, Peterson PK. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 2003;24:116-21.
68. Cooper EL, Parrinello N. Invertebrates, ectotherms, immunono-toxicology: extrapolation to human health. In: Modulators of Immune Responses: The Evolutionary Trail (Stolen JS, Fletcher TC, Bayne CJ et al, eds). Fair Haven NJ: SOS Publications, 1996:331-42.
69. Cooper EL, Parrinello N. Comparative immunological models can enhance analyses of environmental immunotoxicity. Ann Rev Fish Dis 1996; 6: 179-91.